Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer.

Puri, Rajiv; Palit, Victor; Loadman, Paul M; Flannigan, Michael; Shah, Tariq; Choudry, Guzanfar A; Basu, Saurajyoti; Double, John A; Lenaz, Gino; Chawla, Shanta; Beer, Mario; Van Kalken, Coen; de Boer, Richard; Beijnen, Jos H; Twelves, Christopher J; Phillips, Roger M

Puri, Rajiv; Palit, Victor; Loadman, Paul M; Flannigan, Michael; Shah, Tariq; Choudry, Guzanfar A; Basu, Saurajyoti; Double, John A; Lenaz, Gino; Chawla, Shanta; Beer, Mario; Van Kalken, Coen; de Boer, Richard; Beijnen, Jos H; Twelves, Christopher J; Phillips, Roger M.

Affiliation

Puri R; Department of Urology, Bradford Royal Infirmary, Bradford, United Kingdom.

J Urol ; 176(4 Pt 1): 1344-8, 2006 Oct.

Article in En | MEDLINE | ID: mdl-16952628

Subject(s)

Antineoplastic Agents/administration & dosage; Aziridines/administration & dosage; Carcinoma, Transitional Cell/drug therapy; Indolequinones/administration & dosage; Urinary Bladder Neoplasms/drug therapy; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/pharmacokinetics; Aziridines/pharmacokinetics; Carcinoma, Transitional Cell/pathology; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Indolequinones/pharmacokinetics; Male; Middle Aged; Pilot Projects; Treatment Outcome; Urinary Bladder Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Aziridines / Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Indolequinones / Antineoplastic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2006 Type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links